Opioid Manufacturer Purdue Pharma Sentenced for Fraud and Kickback Conspiracies

WASHINGTON — Opioid manufacturer Purdue Pharma LP (Purdue) was sentenced today in federal court in Newark, New Jersey, and ordered to pay criminal penalties of over $5 billion for its role in fueling the opioid epidemic. “Purdue Pharma put profits over patient health and safety,” said Acting Attorney General Todd Blanche. “The company willfully rejected the law and ignored the diversion of their highly addictive prescription drugs. Their actions contributed to the opioid crisis that claimed countless lives and destroyed entire families and communities. Today's sentence is a prime example of the Department’s effort to redress past wrongs by rooting out and punishing unlawful conduct by companies that have contributed to the national crisis.” “The opioid epidemic in the United States is a plague that has ruined lives and destroyed families,” said FBI Director Kash Patel. “Purdue Pharma complicitly contributed to this national epidemic in the name of their own greed by blatantly ignoring the health and safety of patients putting countless lives at risk. The FBI and our DOJ partners will always work tirelessly to ensure that companies, like Pharma, pay for the harm they have inflicted and warn others that they will not get away with violating the law for personal gain.” “This generational case against Purdue Pharmaceuticals is one of the most important corporate enforcement cases ever brought by the Department of Justice,” said Assistant Attorney General A. Tysen Duva of the Justice Department’s Criminal Division. “The opioid epidemic was and continues to be a national tragedy that has destroyed far too many lives, families, and communities. Purdue callously focused on profits when it knew that providers were prescribing these addictive opioids to patients without a legitimate medical purpose. While good progress has been made in combating the national opioid crisis, today’s sentencing is a reminder that there is much additional work to be done. Companies like Purdue that place illicit profits over the obligation to be a good and honest corporate citizen will be investigated and prosecuted. Today’s sentencing reflects Purdue’s role in fueling the opioid crisis and concludes the Department’s efforts to hold Purdue accountable for diversion of its products. The Criminal Division remains steadfast in our mission to seek justice on behalf of the American people.” “Purdue Pharma undermined the government’s efforts to ensure compliance and prevent prescription drug diversion,” said Administrator Terrance Cole of the Drug Enforcement Administration (DEA). “Their actions fueled a surge in addiction and cost many Americans lives. The prescription opioid epidemic directly paved the way for today’s fentanyl crisis. DEA remains committed to working with registrants, communities, faith-based organizations, and schools to address the damage and end the opioid epidemic that has gripped our nation for far too long.” “Purdue Pharma put profit ahead of American lives and, in doing so, helped engineer a public health catastrophe that has left a trail of suffering for families and communities across this nation,” said Inspector General T. March Bell of the U.S. Department of Health and Human Services Office of Inspector General (HHS OIG). “No penalty can undo the widespread devastation Purdue has inflicted, but today’s sentence serves long overdue accountability for its reckless and unlawful conduct. HHS OIG and our law enforcement partners will continue to investigate large corporations and conglomerates when they violate the Anti Kickback Statute and other federal laws designed to protect patients and the integrity of federally funded health care programs.” “Purdue made billions by unlawfully marketing dangerous opioid products, and deceiving the DEA and the American people,” said U.S. Attorney Robert Frazer for the District of New Jersey. “Purdue profited by paying illegal kickbacks to induce providers, including those who diverted opioids to drug